Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Hsp90 inhibitor XL888
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: MCC-17013, NCI-2012-01380, NCT01657591
Start Over